| Product Code: ETC12762894 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sachin Kumar Rai | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Non-Hodgkin's Lymphoma Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Non-Hodgkin's Lymphoma Market Revenues & Volume, 2021 & 2031F |
3.3 India Non-Hodgkin's Lymphoma Market - Industry Life Cycle |
3.4 India Non-Hodgkin's Lymphoma Market - Porter's Five Forces |
3.5 India Non-Hodgkin's Lymphoma Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 India Non-Hodgkin's Lymphoma Market Revenues & Volume Share, By Therapy Type, 2021 & 2031F |
3.7 India Non-Hodgkin's Lymphoma Market Revenues & Volume Share, By Diagnosis Method, 2021 & 2031F |
3.8 India Non-Hodgkin's Lymphoma Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 India Non-Hodgkin's Lymphoma Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing incidence and prevalence of non-Hodgkin's lymphoma in India |
4.2.2 Growing awareness and early diagnosis of the disease |
4.2.3 Advancements in treatment options and therapies for non-Hodgkin's lymphoma patients |
4.3 Market Restraints |
4.3.1 High treatment costs and lack of affordability for a significant portion of the population |
4.3.2 Limited access to specialized healthcare facilities and oncologists in certain regions of India |
5 India Non-Hodgkin's Lymphoma Market Trends |
6 India Non-Hodgkin's Lymphoma Market, By Types |
6.1 India Non-Hodgkin's Lymphoma Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 India Non-Hodgkin's Lymphoma Market Revenues & Volume, By Type, 2021 - 2031F |
6.1.3 India Non-Hodgkin's Lymphoma Market Revenues & Volume, By B-cell Lymphoma, 2021 - 2031F |
6.1.4 India Non-Hodgkin's Lymphoma Market Revenues & Volume, By T-cell Lymphoma, 2021 - 2031F |
6.1.5 India Non-Hodgkin's Lymphoma Market Revenues & Volume, By Follicular Lymphoma, 2021 - 2031F |
6.2 India Non-Hodgkin's Lymphoma Market, By Therapy Type |
6.2.1 Overview and Analysis |
6.2.2 India Non-Hodgkin's Lymphoma Market Revenues & Volume, By Chemotherapy, 2021 - 2031F |
6.2.3 India Non-Hodgkin's Lymphoma Market Revenues & Volume, By Immunotherapy, 2021 - 2031F |
6.2.4 India Non-Hodgkin's Lymphoma Market Revenues & Volume, By Targeted Therapy, 2021 - 2031F |
6.3 India Non-Hodgkin's Lymphoma Market, By Diagnosis Method |
6.3.1 Overview and Analysis |
6.3.2 India Non-Hodgkin's Lymphoma Market Revenues & Volume, By Imaging, 2021 - 2031F |
6.3.3 India Non-Hodgkin's Lymphoma Market Revenues & Volume, By Biopsy, 2021 - 2031F |
6.3.4 India Non-Hodgkin's Lymphoma Market Revenues & Volume, By Blood Tests, 2021 - 2031F |
6.4 India Non-Hodgkin's Lymphoma Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 India Non-Hodgkin's Lymphoma Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.4.3 India Non-Hodgkin's Lymphoma Market Revenues & Volume, By Clinics, 2021 - 2031F |
6.4.4 India Non-Hodgkin's Lymphoma Market Revenues & Volume, By Research Centers, 2021 - 2031F |
7 India Non-Hodgkin's Lymphoma Market Import-Export Trade Statistics |
7.1 India Non-Hodgkin's Lymphoma Market Export to Major Countries |
7.2 India Non-Hodgkin's Lymphoma Market Imports from Major Countries |
8 India Non-Hodgkin's Lymphoma Market Key Performance Indicators |
8.1 Average time from diagnosis to treatment initiation |
8.2 Patient survival rate post-treatment |
8.3 Number of clinical trials and research studies focusing on non-Hodgkin's lymphoma in India |
9 India Non-Hodgkin's Lymphoma Market - Opportunity Assessment |
9.1 India Non-Hodgkin's Lymphoma Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 India Non-Hodgkin's Lymphoma Market Opportunity Assessment, By Therapy Type, 2021 & 2031F |
9.3 India Non-Hodgkin's Lymphoma Market Opportunity Assessment, By Diagnosis Method, 2021 & 2031F |
9.4 India Non-Hodgkin's Lymphoma Market Opportunity Assessment, By End User, 2021 & 2031F |
10 India Non-Hodgkin's Lymphoma Market - Competitive Landscape |
10.1 India Non-Hodgkin's Lymphoma Market Revenue Share, By Companies, 2024 |
10.2 India Non-Hodgkin's Lymphoma Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here